The Virus Project will begin production of a White Paper and documentary on reopening schools and keeping them open. Research will focus on the K-12 schools that stayed open during the pandemic. The goal is a multimedia asset that addresses this issue and help schools everywhere reopen. The Virus Project was formed to aggregate the best ideas and thinking to provide a platform for innovators to collaborate and find solutions to the COVID-19 crisis. K-12 schools is an area of significant challenge but with noticeable progress. White Paper and Research Study: K-12 schools. Dealing with COVID-19. This White Paper will…
Browsing: library
Earlier this month, Kontrol Energy’s BioCloud technology received a two million dollar investment from the Ontario government. Kontrol, a Canadian energy company with international collaborators, was founded in 2015, and has made a name for itself through it’s use of technological innovation to address modern problems, such as energy efficiency, air quality and carbon emissions. Kontrol’s new BioCloud technology is a system designed to detect the ambient presence of COVID-19 in indoor air, and marks the company’s first shift to pandemic era solutions. While coronavirus air testing has recently experienced a technological boom, with companies such as eurofins, AssuredBio, and PathogenDx offering their own air testing technologies, the BioCloud system stands out as the sole…
“Big Pharma” is less important today than it was five years ago. The top eighteen pharmaceutical companies today comprise less than half the value of the sector whereas in 2003 they accounted for over three quarters of the sectors value.
A profile on 160 companies with meaningful products related to improving the quality and reach of diagnostic testing related to coronavirus. The Race to the Test our mission is to reopen.
FasterCures, a center of the Milken Institute, is currently tracking the development of treatments and vaccines for COVID-19 (coronavirus). This tracker contains an aggregation of publicly-available information from validated sources. According to Milken there are: 316 Treatments in 7 categories are being developed now. 212 Vaccines in development in 9 categories. 34 of which are now in testing. The leading vaccine candidates as of mid September 2020 are listed here.
Global Overview of COVID-19 Testing. The Development of a Core Curriculum. The Virus Project commissioned a research report by BALSA a consulting enterprise operating from the Washington University in St. Louis. The report provides an overview of the scientific, regulatory and market issues for the COVID-19 testing in the United States. It is an exceptional resource for understanding the COVID testing marketplace. The report provides an over view of this new market that largely did not exist in January 2020 but could reach $20 billion in revenues in 2021. It would be the fastest market growth for a dead start…
Market Overview was prepared by a team from Cambridge University. The objective was understanding of the testing market in Europe. The report also offers insight into Asia. The 50 page deck examined the COVID testing market broadly and assessed a variety of market dynamics: Market size for PCR and Antibody tests The different business models employed Regulatory pathways Supply chain analysis including bottlenecks. Regulatory landscape. Including a detailed flow chart analyzing zing the complexity of approval process in the EU, China and South Korea. Also included was the commercialization landscape and the reimbursement analysis for France, Germany, UK, Spain and…